The company states: “Vir Biotechnology (VIR) announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading ...

Vir Biotechnology ( ($VIR) ) just unveiled an update. On December 16, 2025, Vir Biotechnology entered into a license agreement with Norgine Pharma ...

Virginia International Raceway has acquired full ownership of the land it operates on, ending a decades-long lease and ...

Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...

VIRginia International Raceway announced today that it has officially acquired full ownership of the land that the historic ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.

ALTON, Va. (WFXR) – The VIRginia International Raceway (VIR) has announced this year is its 25th anniversary and is gearing up to celebrate with high-octane heart-pumping thrills all season.

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in hepatitis B while it seeks a suitable partner. Back in November, Vir arrived ...

Vir Biotechnology (NASDAQ:VIR) drives healthcare innovation and plays a central role in discussions linked to Nasdaq Index ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational combo of ...

HALIFAX COUNTY, Va. (WDBJ) - A core piece of history is growing at the Virginia International Raceway. Many people don’t tend to think about trees when they’re at a racetrack, but for VIR fans, that’s ...

- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025 - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA ...